Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness

Daisuke Kamimura, Takeki Suzuki, Anna L. Furniss, Michael E. Griswold, Iftikhar J. Kullo, Merry L Lindsey, Michael D. Winniford, Kenneth R. Butler, Thomas H. Mosley, Michael E. Hall

Research output: Contribution to journalArticle

Abstract

Aim Osteoprotegerin (OPG) is associated with a poor prognosis in patients with heart failure with preserved ejection fraction (HFpEF). OPG has also been associated with fibrosis and collagen cross-linking, which increase arterial and left ventricle (LV) myocardial stiffness. Little is known about the relation of OPG and LV structure and function in African-Americans who are disproportionately affected by HFpEF. Methods and results Our analysis included 1172 participants with preserved LV ejection fraction (>50%) from the African-American cohort in the Genetic Epidemiology Network of Arteriopathy Study (mean age 63 years, 72% female). We used diastolic wall strain indicator measured by echocardiography to assess LV myocardial stiffness. Diastolic wall strain was calculated as (LV posterior thickness at end-systole-LV posterior thickness at end-diastole)/LV posterior thickness at end-systole. Associations between OPG levels and indices of arterial and LV structure and function were evaluated by using generalized linear mixed models and adjusted for possible confounders. OPG levels were correlated with age, female sex, presence of hypertension and diabetes, and lower estimated glomerular filtration rate (P < 0.05 for all). Multivariable analysis revealed that higher OPG levels were associated with greater LV mass index, increased LV myocardial stiffness, and higher N-terminal prohormone brain natriuretic peptide levels (P < 0.05 for all). Conclusion In African-Americans, higher OPG levels were associated with characteristics common in patients with HFpEF and were significantly associated with known precursors to HFpEF. These findings indicate a potential role for OPG in the pathophysiology of HFpEF in African-Americans.

Original languageEnglish (US)
Pages (from-to)954-961
Number of pages8
JournalJournal of Cardiovascular Medicine
Volume18
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Osteoprotegerin
Heart Ventricles
Serum
Heart Failure
African Americans
Systole
Diastole
Molecular Epidemiology
Brain Natriuretic Peptide
Glomerular Filtration Rate
Echocardiography
Linear Models
Fibrosis
Collagen
Hypertension

Keywords

  • African-Americans
  • diastolic dysfunction
  • myocardial stiffness
  • osteoprotegerin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness. / Kamimura, Daisuke; Suzuki, Takeki; Furniss, Anna L.; Griswold, Michael E.; Kullo, Iftikhar J.; Lindsey, Merry L; Winniford, Michael D.; Butler, Kenneth R.; Mosley, Thomas H.; Hall, Michael E.

In: Journal of Cardiovascular Medicine, Vol. 18, No. 12, 01.12.2017, p. 954-961.

Research output: Contribution to journalArticle

Kamimura, D, Suzuki, T, Furniss, AL, Griswold, ME, Kullo, IJ, Lindsey, ML, Winniford, MD, Butler, KR, Mosley, TH & Hall, ME 2017, 'Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness', Journal of Cardiovascular Medicine, vol. 18, no. 12, pp. 954-961. https://doi.org/10.2459/JCM.0000000000000549
Kamimura, Daisuke ; Suzuki, Takeki ; Furniss, Anna L. ; Griswold, Michael E. ; Kullo, Iftikhar J. ; Lindsey, Merry L ; Winniford, Michael D. ; Butler, Kenneth R. ; Mosley, Thomas H. ; Hall, Michael E. / Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness. In: Journal of Cardiovascular Medicine. 2017 ; Vol. 18, No. 12. pp. 954-961.
@article{a0d377278a2440c8a4b3c317f978157e,
title = "Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness",
abstract = "Aim Osteoprotegerin (OPG) is associated with a poor prognosis in patients with heart failure with preserved ejection fraction (HFpEF). OPG has also been associated with fibrosis and collagen cross-linking, which increase arterial and left ventricle (LV) myocardial stiffness. Little is known about the relation of OPG and LV structure and function in African-Americans who are disproportionately affected by HFpEF. Methods and results Our analysis included 1172 participants with preserved LV ejection fraction (>50{\%}) from the African-American cohort in the Genetic Epidemiology Network of Arteriopathy Study (mean age 63 years, 72{\%} female). We used diastolic wall strain indicator measured by echocardiography to assess LV myocardial stiffness. Diastolic wall strain was calculated as (LV posterior thickness at end-systole-LV posterior thickness at end-diastole)/LV posterior thickness at end-systole. Associations between OPG levels and indices of arterial and LV structure and function were evaluated by using generalized linear mixed models and adjusted for possible confounders. OPG levels were correlated with age, female sex, presence of hypertension and diabetes, and lower estimated glomerular filtration rate (P < 0.05 for all). Multivariable analysis revealed that higher OPG levels were associated with greater LV mass index, increased LV myocardial stiffness, and higher N-terminal prohormone brain natriuretic peptide levels (P < 0.05 for all). Conclusion In African-Americans, higher OPG levels were associated with characteristics common in patients with HFpEF and were significantly associated with known precursors to HFpEF. These findings indicate a potential role for OPG in the pathophysiology of HFpEF in African-Americans.",
keywords = "African-Americans, diastolic dysfunction, myocardial stiffness, osteoprotegerin",
author = "Daisuke Kamimura and Takeki Suzuki and Furniss, {Anna L.} and Griswold, {Michael E.} and Kullo, {Iftikhar J.} and Lindsey, {Merry L} and Winniford, {Michael D.} and Butler, {Kenneth R.} and Mosley, {Thomas H.} and Hall, {Michael E.}",
year = "2017",
month = "12",
day = "1",
doi = "10.2459/JCM.0000000000000549",
language = "English (US)",
volume = "18",
pages = "954--961",
journal = "Journal of Cardiovascular Medicine",
issn = "1558-2027",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness

AU - Kamimura, Daisuke

AU - Suzuki, Takeki

AU - Furniss, Anna L.

AU - Griswold, Michael E.

AU - Kullo, Iftikhar J.

AU - Lindsey, Merry L

AU - Winniford, Michael D.

AU - Butler, Kenneth R.

AU - Mosley, Thomas H.

AU - Hall, Michael E.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Aim Osteoprotegerin (OPG) is associated with a poor prognosis in patients with heart failure with preserved ejection fraction (HFpEF). OPG has also been associated with fibrosis and collagen cross-linking, which increase arterial and left ventricle (LV) myocardial stiffness. Little is known about the relation of OPG and LV structure and function in African-Americans who are disproportionately affected by HFpEF. Methods and results Our analysis included 1172 participants with preserved LV ejection fraction (>50%) from the African-American cohort in the Genetic Epidemiology Network of Arteriopathy Study (mean age 63 years, 72% female). We used diastolic wall strain indicator measured by echocardiography to assess LV myocardial stiffness. Diastolic wall strain was calculated as (LV posterior thickness at end-systole-LV posterior thickness at end-diastole)/LV posterior thickness at end-systole. Associations between OPG levels and indices of arterial and LV structure and function were evaluated by using generalized linear mixed models and adjusted for possible confounders. OPG levels were correlated with age, female sex, presence of hypertension and diabetes, and lower estimated glomerular filtration rate (P < 0.05 for all). Multivariable analysis revealed that higher OPG levels were associated with greater LV mass index, increased LV myocardial stiffness, and higher N-terminal prohormone brain natriuretic peptide levels (P < 0.05 for all). Conclusion In African-Americans, higher OPG levels were associated with characteristics common in patients with HFpEF and were significantly associated with known precursors to HFpEF. These findings indicate a potential role for OPG in the pathophysiology of HFpEF in African-Americans.

AB - Aim Osteoprotegerin (OPG) is associated with a poor prognosis in patients with heart failure with preserved ejection fraction (HFpEF). OPG has also been associated with fibrosis and collagen cross-linking, which increase arterial and left ventricle (LV) myocardial stiffness. Little is known about the relation of OPG and LV structure and function in African-Americans who are disproportionately affected by HFpEF. Methods and results Our analysis included 1172 participants with preserved LV ejection fraction (>50%) from the African-American cohort in the Genetic Epidemiology Network of Arteriopathy Study (mean age 63 years, 72% female). We used diastolic wall strain indicator measured by echocardiography to assess LV myocardial stiffness. Diastolic wall strain was calculated as (LV posterior thickness at end-systole-LV posterior thickness at end-diastole)/LV posterior thickness at end-systole. Associations between OPG levels and indices of arterial and LV structure and function were evaluated by using generalized linear mixed models and adjusted for possible confounders. OPG levels were correlated with age, female sex, presence of hypertension and diabetes, and lower estimated glomerular filtration rate (P < 0.05 for all). Multivariable analysis revealed that higher OPG levels were associated with greater LV mass index, increased LV myocardial stiffness, and higher N-terminal prohormone brain natriuretic peptide levels (P < 0.05 for all). Conclusion In African-Americans, higher OPG levels were associated with characteristics common in patients with HFpEF and were significantly associated with known precursors to HFpEF. These findings indicate a potential role for OPG in the pathophysiology of HFpEF in African-Americans.

KW - African-Americans

KW - diastolic dysfunction

KW - myocardial stiffness

KW - osteoprotegerin

UR - http://www.scopus.com/inward/record.url?scp=85033785316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033785316&partnerID=8YFLogxK

U2 - 10.2459/JCM.0000000000000549

DO - 10.2459/JCM.0000000000000549

M3 - Article

VL - 18

SP - 954

EP - 961

JO - Journal of Cardiovascular Medicine

JF - Journal of Cardiovascular Medicine

SN - 1558-2027

IS - 12

ER -